This study compared how VIP, VIP antibodies, and VIP antagonists including a modified GRF peptide affected nerve-driven muscle contractions in dog and cat airways. VIP reduced nerve-stimulated contractions and electrical signals in airway smooth muscle by acting on nerve terminals rather than the muscle itself. However, the VIP antagonists tested, including the GRF-derived compound, were largely ineffective at blocking these neural effects, suggesting they may not interact well with the specific VIP receptor type present in airway tissue.
Hakoda, H; Ito, Y